Literature DB >> 23433606

Factors associated with effective reassessment of antibiotic therapy on day 3.

P-M Roger1, C Labate, S Serre, C Zumbo, L Valério, H Bonnet, A Jurado, N Bélé, P Brofferio.   

Abstract

UNLABELLED: Reassessment of antibiotic therapy (RA) after 3 days is constitutive of French antibiotic stewardship. This delay is required because of the need for clinical reappraisal and for obtaining microbiological data. Our aim was to determine the factors associated with an effective RA. PATIENTS AND
METHOD: A prospective study was made in a 350-bed general hospital in which all prescriptions are computerized and validated daily by prescribers. All curative antibiotic therapies were reassessed during 4 weeks. RA was defined as effective if the initial antibiotic treatment was modified. All clinical, biological, and radiological data having contributed to the initial prescription and to RA were recorded during bedside visit with the prescribers, two hospital physicians and one infectious diseases specialist.
RESULTS: In one month, 148 antibiotic treatments were reassessed. Pulmonary, digestive, and urinary infections accounted for two thirds of the cases. An effective RA was recorded in 28 cases (19%) and associated with hospitalization in the ICU (P=0.001), imaging supporting the diagnosis (P=0.016), and persistence or aggravation of clinical signs (P=0.007). Microbiological findings were not contributive to an effective RA.
CONCLUSION: RA was associated to hospitalization in the ICU, to an inflammatory syndrome, and to the clinical outcome after 3 days. These results should help to improve the implementation of infectious diseases advice.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23433606     DOI: 10.1016/j.medmal.2012.12.007

Source DB:  PubMed          Journal:  Med Mal Infect        ISSN: 0399-077X            Impact factor:   2.152


  1 in total

1.  Bacteraemia in emergency departments: effective antibiotic reassessment is associated with a better outcome.

Authors:  Charlotte Aillet; Didier Jammes; Agnès Fribourg; Sophie Léotard; Olivier Pellat; Patricia Etienne; Dominique Néri; Djamel Lameche; Olivier Pantaloni; Serge Tournoud; Pierre-Marie Roger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-11-21       Impact factor: 3.267

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.